AJA Life Sciences Advisory

Executive Advisory at the Intersection of Science, Strategy, and Leadership

Founded and led by Dr. Aparna Ahuja, MD — Physician Executive

We provide trusted advisory at the moments that define organizations. Physician Executive–led, our firm integrates scientific insight, enterprise strategy, evidence generation, operational excellence, and organizational leadership.

Dr Aparna Ahuja has led medical and clinical strategy at Becton Dickinson and Abbott—two of the world’s leading global healthcare organizations as well as T2 Biosystems, an innovative, high-growth diagnostics company. This combination brings:

  • The rigor, scale, and governance of global organizations
  • The agility, speed, and innovation mindset of emerging companies
  • A practical understanding of how to translate strategy into execution across different stages of growth

Key Metrics

30+
Years of Experience Including 20+ years of executive leadership
100+
Clinical Studies Managed Regulatory submissions & evidence generation
4
Regions of Impact North America, EMEA, APAC, LATAM
$B+
Portfolio Scale Multi-billion diagnostics & medical device portfolios
10,000+
Engagements

Advising

CEOs Founders Boards Directors CMOs Investors PE Innovation Leaders R&D Leaders Public Health Leaders Lab Directors Government Leaders

Across

Pharma Biotech Diagnostics Precision Medicine Health Tech Clinical Labs National Health Agencies

When Decisions Matter Most

Consequential. Complex. Irreversible. When you need independent judgment to navigate uncertainty, frame decisions, and align scientific rigor with enterprise value.

Consequential Moments

Decisions that shape the trajectory of enterprises, portfolios, and teams. We bring clarity when the stakes are highest.

Navigate Uncertainty

Complex, multi-variable situations demand more than frameworks—they demand judgment honed through decades of operational leadership.

Rigor Meets Value

Aligning scientific evidence, regulatory pathways, and commercial strategy into a coherent enterprise narrative that drives outcomes.

Executive Advisory

Eight advisory domains. Each grounded in operating experience, delivered at the executive level.

01

Executive & Board Advisory

C-suite and board-level advisory on strategic direction, organizational design, and enterprise decision-making.

02

Portfolio & Pipeline Strategy

Optimizing portfolio prioritization, pipeline valuation, and investment allocation for maximum enterprise impact.

03

Clinical-Commercial Integration

Bridging the gap between clinical evidence generation and commercial strategy for seamless go-to-market execution.

04

Partnerships & Business Development

Structuring strategic alliances and partnership frameworks that accelerate growth.

05

Precision Medicine, Diagnostics & MedTech

Deep domain advisory across companion diagnostics, molecular testing, and precision health strategy.

06

Investor & PE Advisory

Due diligence, market assessment, and strategic evaluation for investors and private equity in life sciences.

07

Operational Excellence

Driving efficiency, governance, and scalable operating models across medical affairs and commercial organizations. From strategy through implementation.

08

Laboratory Systems & Operational Excellence

Workflow optimization. Accreditation support. Lean Six Sigma frameworks. Alignment of lab performance with outcomes.

Domains of Depth

Our firm brings specialized knowledge built through decades of hands-on leadership across global life sciences.

Medical Affairs Strategy

Precision Medicine, Diagnostics & MedTech

Clinical Development

Portfolio Strategy

Clinical-Commercial Alignment

RWE & HEOR

Strategic Partnerships

Product Lifecycle Management

Focused. Confidential. Senior-Led.

Three engagement models—each direct, scoped, and trust-based. No teams of juniors. No bloated scopes.

1

Strategic Advisory

Ongoing advisory relationship with direct access. Retained engagements for C-suite and board-level leaders navigating complex decisions.

Retained
2

Scoped Engagement

Defined deliverable, clear timeline. Ideal for due diligence, portfolio reviews, market assessments, product launch activities, clinical programs, and strategic planning cycles.

Project-Based
3

Expert Consultation

Focused, high-impact sessions for specific questions, regulatory & clinical compliance, investor diligence calls, or board preparation. Rapid-turnaround advisory.

On-Demand

Founder & Principal

Dr. Aparna Ahuja

Dr. Aparna Ahuja, MD, is the founder and principal of AJA Life Sciences Advisory. A physician-executive and senior leader in global life sciences, she brings more than three decades of experience across healthcare innovation systems, medical affairs, clinical development, in-vitro diagnostics, precision medicine, MedTech, clinical diagnostics & research laboratories, commercial strategy, regulatory and clinical compliance, and with executive roles at Becton Dickinson, Abbott, T2 Biosystems, Agilus Diagnostics (formerly SRL), and Dr Lal PathLabs.

Trusted advisor to executive teams and boards on clinical strategy, evidence generation, regulatory pathways, and enterprise decision-making. Recognized for building and leading global organizations that translate science into strategy, and strategy into adoption, across complex healthcare ecosystems.

Dr. Ahuja’s work sits at the intersection of scientific rigor, enterprise strategy, and healthcare transformation—helping organizations navigate high-stakes decisions with clarity, independence, and depth. She founded AJA Life Sciences Advisory to bring that perspective directly to CEOs, boards, investors, and innovation leaders.

Learn More About Dr. Ahuja LinkedIn Profile

Ready to Have the Conversation
That Matters?

AJA Life Sciences Advisory works with a limited number of clients to ensure depth, focus, and confidentiality. If you're facing a consequential decision, we'd welcome the conversation.

inquiry@ajalifesciencesadvisory.net